These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1970 related articles for article (PubMed ID: 16737625)
21. [Diagnosis and surgical treatment for stage I non-small-cell lung cancer]. Gao YS; Zhang DC; He J; Sun KL; Zhang DW; Zhang RG Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):52-5. PubMed ID: 15771801 [TBL] [Abstract][Full Text] [Related]
22. [Sleeve resection for lung cancer: a report of 82 cases]. Chen PC; Zhou XM; Chen QX; Liu JS; Yan FL; Jiang YH Ai Zheng; 2008 May; 27(5):510-5. PubMed ID: 18479601 [TBL] [Abstract][Full Text] [Related]
23. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC. Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624 [TBL] [Abstract][Full Text] [Related]
24. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer. Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118 [TBL] [Abstract][Full Text] [Related]
25. [Experience of surgical treatment of patients with N2 lung cancer]. Qu J; Hou W; Shi N Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):376-8. PubMed ID: 9387280 [TBL] [Abstract][Full Text] [Related]
26. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
27. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer]. Yu DP; Bai LQ; Xu SF; Han M; Wang ZT Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561 [TBL] [Abstract][Full Text] [Related]
28. [Metastases to the mediastinal lymph nodes in lung cancer and their extensive dissection]. Li Y; Li H; Hu Y Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):303-5. PubMed ID: 11038766 [TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Casali C; Stefani A; Natali P; Rossi G; Morandi U Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734 [TBL] [Abstract][Full Text] [Related]
30. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved. Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349 [TBL] [Abstract][Full Text] [Related]
31. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases. Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543 [TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986 [TBL] [Abstract][Full Text] [Related]
33. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203 [TBL] [Abstract][Full Text] [Related]
35. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
36. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy. Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087 [TBL] [Abstract][Full Text] [Related]
37. [T1, T2 squamous or adenocarcinoma of the lung:characteristics of lymph node metastasis and its clinical significance]. Li Y; Liu H; Li H; Hu Y; Yin H Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):432-4. PubMed ID: 11832076 [TBL] [Abstract][Full Text] [Related]
38. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy? Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121 [TBL] [Abstract][Full Text] [Related]
40. [Impact of the number of resected and involved lymph nodes on the outcome in patients with stage II non-small cell lung cancer]. Dai Y; Long H; Lin P; Fu JH; Zhang LJ; Zhu ZH; Zhang X; Rong TH; Su XD Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):436-40. PubMed ID: 20819485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]